Iovance Biotherapeutics (IOVA) Stock: Buy, Sell, or Hold?
IOVA - Iovance Biotherapeutics, Inc. Common Stock
$14.14
-0.48 (-3.28%)
âŧ
5d:
-3.94%
30d:
+38.76%
90d:
+183.37%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 19, 2026 at $14.29 · last confirmed Oct 20, 2026
Strength: 8.1/10
Get Alerted When IOVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IOVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IOVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IOVA is currently trading at $14.14, which is considered slightly high relative to its 30-day fair value range of $10.68 to $14.67.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $13.29, while resistance sits at $15.37. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: IOVA scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $13.29, while resistance sits at $15.37. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: IOVA scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.68 -
$14.67
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.6%
All Signals
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- NEUTRAL: Near Wall St target ($14.40)
- WARNING: Composite score 30/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.68 -
$14.67
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.29
Resistance Level
$15.37
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-72.22
Wall Street Target
$14.40
(+1.8%)
Revenue Growth (YoY)
65.7%
Profit Margin
-89.1%
Share & Embed Analysis
Last updated: October 22, 2026 10:23 PM ET
Data refreshes hourly during market hours. Next update: 11:23 PM
Data refreshes hourly during market hours. Next update: 11:23 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 59 HOLD |
|
RYTM
Rhythm Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$144 | 70 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 56 HOLD |
